Health Industry

"Health Industry" Main

Latest Morning Briefing Stories

Possible Mass Exodus Brewing At Gilead As Another Top Official Announces Departure

KHN Morning Briefing

The moves add to growing investor unease over the health of large biotech companies, which are being pushed to find successors for aging blockbuster drugs. In other pharmaceutical news: Pfizer invests in a better flu vaccine; a startup struggles to build interest by male doctors for a drug that benefits women; and a deeper look at CAR-T therapy.

In Second Month Of Arkansas’ Work Requirements, Thousands Fail To Report Hours Even Though They Meet Them

KHN Morning Briefing

The beneficiaries have to log hours through other programs, so officials know that they’re meeting them and simply just not reporting them. Critics warned of this scenario before work requirements were instituted because, according to analysts, one in three Medicaid adults never use a computer or the internet and four in ten do not use email. Medicaid news comes out of Ohio, as well.

New York Sues Purdue Pharma, Accuses Opioid Maker Of Widespread Fraud

KHN Morning Briefing

New York joins dozens of other states suing the manufacturer of OxyContin. “The opioid epidemic was manufactured by unscrupulous distributors who developed a $400 billion industry pumping human misery into our communities,” Gov. Andrew Cuomo (D-N.Y.) said.

Activist Investor Icahn Drops Opposition To Cigna-Express Scripts Deal After Advisory Firms Signal Their Support

KHN Morning Briefing

Billionaire Carl Icahn had called the deal a “$60 billion folly,” but is now walking back his opposition in light of recommendations from Institutional Shareholder Services and Glass Lewis. The latter called the insurer’s offer for the pharmacy benefits manager “both strategically and financially compelling, structured in a reasonable manner from a valuation standpoint for Cigna shareholders.”